NEFL and stroke disorder: Besides its promise as a biomarker for PSCID, some studies suggest that NfL may hold diagnostic value for distinguishing stroke subtype (Sanchez et al., 2022) and prognostic value for assessing mortality, recurrent stroke risk, and cardiovascular outcomes (Uphaus et al., 2019; Gendron et al., 2020).